Global Dialyzer Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

DUBLIN, May 17, 2022 /PRNewswire/ -- The "Dialyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global dialyzer market reached a value of US$ 3.29 billion in 2021. Looking forward, the market is projected to reach a value of US$ 4.54 billion by 2027, exhibiting a CAGR of 5.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A dialyzer, also known as an artificial kidney, is an apparatus manufactured using a thin and fibrous material to form a semipermeable membrane, which allows smaller particles and liquids to pass through. It is a cost-effective solution that removes excess fluids and wastes from the blood when kidneys are unable to function properly and prevents accumulation of salt and poisoning. It offers several advantages, such as less waste disposal, minimizing environmental impact, decreasing the frequency of first use syndrome, and improving biocompatibility. As a result, it finds extensive applications in in-center dialysis and home dialysis across the globe.

Dialyzer Market Trends

At present, there is a rise in the prevalence of diabetes, hypertension, heart disease, and end-stage renal diseases (ESRD) among individuals. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing funding on improving dialysis products and services by governments of several countries is propelling the growth of the market.

In addition, the shortage of kidneys for transplantation across the globe is offering lucrative growth opportunities to key market players. Besides this, the availability of trained medical staff in dialysis centers that provide better services to the patient is positively influencing the market. Additionally, the rising utilization of novel products to treat chronic kidney conditions is catalyzing the demand for dialyzers worldwide. Apart from this, the higher efficiency of high-flux dialyzers to remove large size toxin molecules during the hemodialysis is bolstering the growth of the market. Other growth-inducing factors are the expanding healthcare industry, rising medical tourism, increasing reimbursement policies and technological advancements in the product production process.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Cantel Medical Corporation (Steris plc), Dialife SA, Farmasol, Fresenius Medical Care AG & Co. KGaA, Medica S.p.A., Medtronic plc, Nikkiso Co. Ltd., Nipro Corporation, Shandong Weigao Group Medical Polymer Co. Ltd. and Toray Industries Inc.

Key Questions Answered in This Report

• How has the global dialyzer market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global dialyzer market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the usage type?
• What is the breakup of the market based on the End-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global dialyzer market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Dialyzer Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 High-Flux Dialyzer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Low-Flux Dialyzer
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Usage Type
7.1 Disposable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reusable
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Home Care Settings
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Dialysis Centers
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Asahi Kasei Corporation
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 B. Braun Melsungen AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Baxter International Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Browndove Healthcare (P) Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Cantel Medical Corporation (Steris plc)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Dialife SA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Farmasol
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Fresenius Medical Care AG & Co. KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Medica S.p.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Medtronic plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Nikkiso Co. Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Nipro Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Shandong Weigao Group Medical Polymer Co. Ltd.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
14.3.14 Toray Industries Inc.
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.14.3 Financials
14.3.14.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/59zr1p

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets